Enrich Therapeutics receives $1.7 million grant
Biotechnology startup Enrich Therapeutics, based In Groton, CT and Worcester, MA, has received a $1.7-million grant from the National Institute of Allergy and Infectious Diseases, part...
Home >
Access the latest news, business developments, company updates, industry trends, events and more.
Biotechnology startup Enrich Therapeutics, based In Groton, CT and Worcester, MA, has received a $1.7-million grant from the National Institute of Allergy and Infectious Diseases, part...
A Guilford company that provides artificial intelligence services to the pharmaceutical industry has inked a three-year collaboration with the consumer health division of German drugmaker...
Hundreds of area residents have signed up to participate in a study which will test the effectiveness of a potential vaccine against COVID-19. Yale New...
UConn School of Medicine researchers recently published a paper showing how they successfully inhibited an important receptor implicated in post-stroke damage and recovery. The researchers...
Enrich Therapeutics has been awarded a 24-month Small Business Innovation Research phase II grant in the amount of $1.7 million from the National Institute of Allergy and...
Catalyst Clinical Research has merged with Ce3. The union creates a market-leading oncology CRO solution with a particular expertise working with biotech sponsors on complex cancer...
Evotec is a multi-modality drug discovery alliance and development partnership company focused on rapidly progressing innovative product approaches. They work with companies and academic institutions...
BI Office Hours offers small companies, entrepreneurs, and academicians individual attention in an “office hours” atmosphere. Designed as a consultative “round table” meeting, this pioneering...
A Guilford company has picked up another FDA clearance for its portable MRI machine, this time allowing the device to be used to image the...
A test for the coronavirus that uses saliva rather than a long swab up the nostrils may soon be available for widespread use. The test...